CommercialMedicare AdvantageDecember 30, 2022
Notification regarding reimbursement changes to COVID-19 laboratory services codes
This communication applies to Commercial and Medicare Advantage plans from Anthem Blue Cross and Blue Shield (Anthem).
Beginning with dates of service on or after April 1, 2023, or the end of the public health emergency (PHE), whichever is later, reimbursement for COVID-19 laboratory service codes may be reduced for participating providers contracted with Anthem.
New COVID-19 laboratory service codes were implemented and reimbursed at rates to meet the needs of providers during the PHE. Reimbursement will now be revised to Anthem's standard reimbursement methodology for the following codes:
U0001 | 86328 | 87426 | 87811 | 0226U |
U0002 | 86408 | 87428 | 0202U | 0240U |
U0003 | 86409 | 87635 | 0223U | 0241U |
U0004 | 86413 | 87636 | 0224U |
|
U0005 | 86769 | 87637 | 0225U |
|
If you have any questions regarding this notice, please contact Provider Services or use Availity* Live Chat, which is available during normal business hours. Go to www.availity.com and select Anthem from the payer spaces drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.
MULTI-BCBS-CRCM-013072-22
PUBLICATIONS: January 2023 Anthem Provider News - Missouri
To view this article online:
Or scan this QR code with your phone